Pharma’s response to COVID-19: Lilly and diabetes careAs part of our series looking at how pharma companies have adapted to the pandemic, Shannon Rush, leader Share XPharma’s response to COVID-19: Lilly and diabetes carehttps://pharmaphorum.com/r-d/views-analysis-r-d/pharmas-response-to-covid-lilly-and-diabetes-care/
Pharma’s response to COVID: GSKA few months into the pandemic, the world is now moving beyond managing the crisis, with more focus Share XPharma’s response to COVID: GSKhttps://pharmaphorum.com/views-analysis-sales-marketing/pharmas-response-to-covid-gsk/
